TRxADE HEALTH, Inc. (MEDS)

TRxADE HEALTH Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.52	0.01	1.09	3.18	5.94	2.89
Short-Term Investments	1.3	1.3	0	0	0	0
Cash & Cash Equivalents	4.82	1.31	1.09	3.18	5.94	2.89
Cash Growth	287.81%	19.73%	-65.60%	-46.43%	105.34%	225.06%
Receivables	9.05	1.23	0.63	0.98	1.89	0.79
Inventory	0.01	0	0.07	0.06	1.26	0.06
Other Current Assets	0.15	0.21	0.3	0.16	0.13	0.06
Total Current Assets	14.03	2.75	2.09	4.37	9.22	3.8
Property, Plant & Equipment	0.19	0.2	1.12	1.33	0.55	0.93
Long-Term Investments	2.5	0	0	0	0	0
Goodwill and Intangibles	0	0	0	0	0	0.73
Other Long-Term Assets	0.02	9.58	0.5	0.06	0.02	0.11
Total Long-Term Assets	2.71	9.78	1.62	1.39	0.57	1.77
Total Assets	16.74	12.53	3.71	5.77	9.79	5.57
Accounts Payable	0.95	1.5	0.53	0.48	0.26	0.33
Current Debt	0.03	0.03	0.36	0.18	0.36	0.09
Other Current Liabilities	1.97	10.03	1.26	0.27	0.23	0.1
Total Current Liabilities	2.95	11.56	2.15	0.93	0.84	0.52
Long-Term Debt	0.17	0.18	1.22	1.07	0.27	0.91
Other Long-Term Liabilities	0	0.26	0	0	0	0
Total Long-Term Liabilities	0.17	0.43	1.22	1.07	0.27	0.91
Total Liabilities	3.12	11.99	3.37	2	1.11	1.43
Total Debt	0.2	0.21	1.58	1.25	0.63	1
Debt Growth	-80.55%	-86.77%	26.86%	98.98%	-37.12%	18.22%
Retained Earnings	-24.67	-33.25	-19.72	-16.25	-10.93	-8.4
Shareholders' Equity	13.62	0.54	0.76	3.77	8.68	4.14
Net Cash / Debt	4.62	1.1	-0.49	1.93	5.31	1.9
Net Cash / Debt Growth	2136.25%	-	-	-63.60%	180.33%	4017.47%
Net Cash Per Share	3.65	0.46	-0.86	3.57	10.34	4.80
Working Capital	11.08	-8.8	-0.05	3.45	8.38	3.28
Book Value Per Share	13.14	0.71	1.35	6.95	16.89	10.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).